Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trialPeter B. Gilbert, Sarah O’Connell, Charlene McDanal et al.|Science|2022Cited by 1.2k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M. El Sahly, Jacqueline M. Miller, Lindsey R. Baden et al.|New England Journal of Medicine|2021Cited by 661
Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)Scott Evans, Henry F. Chambers, Daniel B. Rubin et al.|Clinical Infectious Diseases|2015Cited by 340
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy TrialPeter B. Gilbert, Richard A. Koup, David C. Montefiori et al.|medRxiv|2021Cited by 138
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical TrialDean Follmann, Lindsey R. Baden, Holly Janes et al.|Annals of Internal Medicine|2022Cited by 138